Remdesivir Entèmedyè CAS 946511-97-3 COVID-19 (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride
Manifakti Komèsyal Pwovizyon pou Remdesivir ak entèmedyè ki gen rapò ak kalite siperyè
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilil Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutil ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir metabolit (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Entèmedyè CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo [2,1-f][1,2,4] triazin-4-amine CAS 937046-98-5
Pyrrolo [1,2-F][1,2,4] Triazin-4-Amine CAS 159326-68-8
4-Amino-7-yodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Non Chimik | (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride |
Sinonim | Remdesivir Entèmedyè;L-Alanine 2-Etilbutil Ester Hydrochloride;Remdesivir Amino Ester konpoze;Remdesivir ki gen rapò ak konpoze 8;Remdesivir enpurte 8 |
Nimewo CAS | 946511-97-3 |
Nimewo CAT | RF-PI298 |
Estati Stock | Nan stock, pwodiksyon echèl jiska dè santèn de kilogram |
Fòmil molekilè | C9H20ClNO2 |
Pwa molekilè | 209.71 |
Pwen k ap fonn | 75.0 a 79.0 ℃ |
Sansib | Igroskopik |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud blan pou prèske blan |
Pèt sou siye | ≤1.0% |
Single enpurte | ≤0.50% |
Enpurte total | ≤1.0% |
Metal lou | ≤20ppm |
Pite | ≥99.0% |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Remdesivir (CAS 1809249-37-3);KOVID 19 |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
Shanghai Ruifu Chemical Co, Ltd se manifakti dirijan ak founisè nan (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride (CAS 946511-97-3), li tipikman itilize pou preparasyon Remdesivir (CAS 1809249-37-3). ).Remdesivir, ke yo rele tou GS-5734, se yon nouvo dwòg antiviral nan klas la nan analogue nukleotid devlope pa Gilead Sciences, ak aktivite antiviral efikas (EC50s nan 74 nM pou SARS-CoV ak MERS-CoV nan selil HAE).Nan mwa fevriye 2020, yo te etidye Remdesivir pou tretman eksperimantal maladi COVID-19 (nouvo coronavirus) emèjan.